Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time” by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625–38]

Detalles Bibliográficos
Autor principal: Rosenbloom, Arlan L.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821650/
https://www.ncbi.nlm.nih.gov/pubmed/20169131
http://dx.doi.org/10.1155/2009/429684
_version_ 1782177459719897088
author Rosenbloom, Arlan L.
author_facet Rosenbloom, Arlan L.
author_sort Rosenbloom, Arlan L.
collection PubMed
description
format Text
id pubmed-2821650
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-28216502010-02-18 Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time” by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625–38] Rosenbloom, Arlan L. Int J Pediatr Endocrinol Commentary Hindawi Publishing Corporation 2009 2010-02-08 /pmc/articles/PMC2821650/ /pubmed/20169131 http://dx.doi.org/10.1155/2009/429684 Text en Copyright © 2009 Arlan L. Rosenbloom. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Rosenbloom, Arlan L.
Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time” by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625–38]
title Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time” by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625–38]
title_full Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time” by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625–38]
title_fullStr Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time” by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625–38]
title_full_unstemmed Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time” by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625–38]
title_short Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time” by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625–38]
title_sort recombinant human insulin-like growth factor-1 treatment: prime time or timeout? [commentary on “recombinant human insulin like growth factor-1 treatment: ready for prime time” by bright gm, mendoza jr, rosenfeld rg, endocrinol metab clin n am 2009; 38:625–38]
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821650/
https://www.ncbi.nlm.nih.gov/pubmed/20169131
http://dx.doi.org/10.1155/2009/429684
work_keys_str_mv AT rosenbloomarlanl recombinanthumaninsulinlikegrowthfactor1treatmentprimetimeortimeoutcommentaryonrecombinanthumaninsulinlikegrowthfactor1treatmentreadyforprimetimebybrightgmmendozajrrosenfeldrgendocrinolmetabclinnam20093862538

Ejemplares similares